
- ONCOLOGY Vol 12 No 11
- Volume 12
- Issue 11
Pall Corporation Launches Web Site on Blood Transfusion
One in 20 Americans will require a blood transfusion at some point in their lives. Yet, many remain uninformed about the reason for transfusions, the risks associated with them, and ways to avoid or minimize them. Pall Corporation has launched a
One in 20 Americans will require a blood transfusion at some point in their lives. Yet, many remain uninformed about the reason for transfusions, the risks associated with them, and ways to avoid or minimize them. Pall Corporation has launched a web site--Blood Transfusions: Knowing Your Options--as an educational service to the public. The site can be accessed through the address:
Filtering Leukocytes
It is important for the public to know, says Pall, that if they need a transfusion, they should demand blood that has been filtered to reduce leukocytes and the viruses associated with them. Visitors to http://www.b1oodtransfusion.com will find a card that they can print and carry in their wallets that specifies their wishes regarding any blood products needed in an emergency.
As public awareness of blood-transmitted diseases grows, patients need to understand what the risks, benefits, and their options are when a blood transfusion is called for. Recognizing that fact, industrialized nations are moving toward adopting routine leukocyte filtration as standard practice. Recently, the United Kingdom joined Austria, France, Ireland, Norway, and Portugal, in requiring that leukocyte reduction by prefiltration be implemented to protect public health and safety. The Canadian Red Cross also recently began the use of leukocyte reduction by filtration for all whole-blood-derived platelets. In the United States, where 12 million units of blood are collected annually, 60% to 70% of platelet components are leukocyte-reduced; 20% of red cells are leukocyte-reduced.
Articles in this issue
about 27 years ago
Phase III Results of Second-Generation HIV Protease Inhibitor Reportedabout 27 years ago
Telomerase Rejuvenates Cells Without Causing Malignant Transformationabout 27 years ago
Hoechst Marion Roussel Launches Antiemetic Information Centerabout 27 years ago
Telomerase Rejuvenates Cells Without Causing Malignant Transformationabout 27 years ago
Intraoperative Ultrasound-Guided Cryoablation of Renal Tumorsabout 27 years ago
First Doris Duke Clinical Scientist Awards Announcedabout 27 years ago
Phase III Results of Second-Generation HIV Protease Inhibitor ReportedNewsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.



















































































